Pulmonary arterial hypertension (PAH) continues to have limited survival despite improvements in therapy. Intensive care unit (ICU) and 1-year mortality risk factors include hyponatraemia, elevated proBNP, hyperbilirubinaemia, and the need for vasopressors/inotropes and mechanical ventilation. Read the article in full in ERJ Open Research the European Respiratory Society's fully open access original research journal.
No comments:
Post a Comment